First Investors Equity Income B (FIUBX)

9.18 +0.00  +0.00% Jun 14 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 9.18
Turnover Ratio 23.00%
1 Year Fund Level Flows -203.90M

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -- -0.92% 41
3M -- 3.65% 51
6M -- 11.32% 71
YTD -- -0.03% 80
1Y -- 12.85% 65
3Y -- 8.33% 91
5Y -- 7.54% 85
10Y -- 10.85% 92
15Y -- 7.19% 86
20Y -- 7.38% 98
As of June 14, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.60% 0.60% 0.00%
Stock 99.13% 99.13% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.27% 0.27% 0.00%
As of Dec. 31, 2019

Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.71%
As of Dec. 31, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 2.95%
Communication Services 6.06%
Consumer Cyclical 3.12%
Consumer Defensive 11.90%
Energy 12.21%
Financial Services 15.29%
Healthcare 21.55%
Industrials 8.93%
Real Estate 2.83%
Technology 12.08%
Utilities 3.09%
As of Dec. 31, 2019

Stock Market Capitalization

Giant 30.64%
Large 57.22%
Medium 12.14%
Small 0.00%
Micro 0.00%
As of Dec. 31, 2019

Stock Style Exposure

Large Cap Value 45.97%
Large Cap Blend 38.83%
Large Cap Growth 3.07%
Mid Cap Value 12.14%
Mid Cap Blend 0.00%
Mid Cap Growth 0.00%
Small Cap Value 0.00%
Small Cap Blend 0.00%
Small Cap Growth 0.00%
As of Dec. 31, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
CAG Conagra Brands Inc 3.14% 29.22 -1.25%
CI Cigna Corp 3.13% 200.01 -7.91%
JNJ Johnson & Johnson 3.13% 145.55 -2.92%
MRK Merck & Co Inc 3.12% 81.33 -1.23%
PFE Pfizer Inc 3.11% 34.71 -2.83%
ALL Allstate Corp 3.10% 120.56 -2.48%
LOW Lowe's Companies Inc 3.09% 122.91 -1.92%
COP ConocoPhillips 3.09% 56.40 -3.49%
MMC Marsh & McLennan Companies Inc 3.08% 113.25 -2.66%
INTC Intel Corp 3.08% 61.76 -4.01%
As of Dec. 31, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks total return. The fund invests, under normal circumstances, primarily in companies that the adviser believes are undervalued in the market relative to their long term potential. Under normal circumstances, the fund will invest at least 80% of its net assets (including any borrowings for investment purposes) in equities. For purposes of this 80% policy, equities may include common stock, preferred stock, equity-based exchange-traded funds (ETFs) and instruments that are convertible into common stock, or other instruments that represent an equity position in an issuer.
General
Security Type Mutual Fund
Oldest Share Symbol FIUTX
Equity Style Large Cap/Value
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Value
Prospectus Objective Equity-Income
Fund Owner Firm Name Delaware Funds by Macquarie
Benchmark Index
Russell 1000 Value TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Kristen Bartholdson 0.33 yrs
Nikhil Lalvani 0.33 yrs
Robert Vogel 0.33 yrs

Share Classes

Symbol Share Class
FIUTX A
FIUUX Inst
FIUVX Retirement

Net Fund Flows

1M -9.868M
3M -45.91M
6M -90.99M
YTD -9.868M
1Y -203.90M
3Y -305.78M
5Y -333.41M
10Y -345.12M
As of Jan. 31, 2020

Risk Info

Beta (5Y) --
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) --
Daily Value at Risk (VaR) 1% (All) --
Monthly Value at Risk (VaR) 1% (All) --

Fundamentals

Dividend Yield TTM --
30-Day SEC Yield (8-31-02) 0.02%
7-Day SEC Yield --
Weighted Average PE Ratio 19.24
Weighted Average Price to Sales Ratio 1.057
Weighted Average Price to Book Ratio 2.364
Weighted Median ROE 17.26%
Weighted Median ROA 4.76%
Forecasted Dividend Yield 2.76%
Forecasted PE Ratio 15.49
Forecasted Price to Sales Ratio 1.084
Forecasted Price to Book Ratio 2.126
Number of Holdings 39
As of Dec. 31, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 7.07%
Forecasted Book Value Growth 1.25%
Forecasted Cash Flow Growth 11.12%
Forecasted Earnings Growth 6.71%
Forecasted Revenue Growth 5.48%
As of Dec. 31, 2019

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 1000.00 USD
Minimum Subsequent Investment 0.00 USD
Fees
Actual 12B-1 Fee 1.00%
Actual Management Fee 0.73%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load 4.00%
Maximum Redemption Fee --
Key Dates
Inception Date 1/12/1995
Termination Date
Last Annual Report Date 9/30/2018
Last Prospectus Date 1/31/2019
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.